Stephanie Brown
Papers
1
Total Citations
31
H-Index
1
About
Dr. Stephanie Brown is a leading clinical researcher in radiation oncology, whose work has fundamentally shaped the evidence base for treating localized prostate cancer. Her primary research focus lies in the comparative effectiveness of stereotactic body radiotherapy (SBRT) versus surgery, with a strong emphasis on patient-reported quality-of-life (QoL) outcomes. Dr. Brown’s most notable contribution is her leadership of the landmark PACE-A trial, an international phase 3 randomized controlled trial that directly compared SBRT to surgery for localized prostate cancer. This pivotal study, published in 2023 and already cited 31 times, provided the first high-level randomized evidence on QoL differences between these two standard-of-care modalities. By demonstrating that SBRT offers superior early QoL outcomes, her work has directly empowered patients and clinicians to make more informed, preference-sensitive treatment decisions. Dr. Brown’s research is distinguished by its rigorous methodology and patient-centered focus, bridging a critical gap in the literature. Her findings have been instrumental in establishing SBRT as a viable, less invasive alternative to surgery, and her ongoing work continues to influence international clinical guidelines and practice patterns in radiation oncology.
Research Focus
Key Achievements
Top Papers
- 1